Your email has been successfully added to our mailing list.

×
-0.0074911032028469 -0.0355871886120997 -0.0307651245551602 -0.0569217081850533 -0.0373665480427046 -0.0391459074733096 -0.0213523131672598 -0.0177935943060498
Stock impact report

Chembio Diagnostics Reports Second Quarter 2019 Financial Results

Chembio Diagnostics, Inc. (CEMI) 
Last chembio diagnostics, inc. earnings: 3/12 04:07 pm Check Earnings Report
US:NASDAQ Investor Relations: chembio.com/investors/investor-relations
Company Research Source: GlobeNewswire
MEDFORD, N.Y., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended June 30, 2019. Recent Accomplishments & Highlights Achieved total revenue of $9.6 million for the second quarter of 2019, representing growth of 10% compared to the prior year period;Entered collaboration with Takeda, a global Pharmaceutical Company, to develop a novel point-of-care diagnostic test for an undisclosed biomarker;Received CE Mark for DPP Zika, Dengue, Chikungunya multiplex test; andReceived ANVISA approval for DPP Dengue test. “Our second quarter results demonstrate sustained performance in our core infectious disease business,” said John Sperzel, Chembio’s Chief Executive Officer. “We continue to make advancements positioning our business for growth on multiple fronts. We are expanding commercialization through additional product regulatory approv Show less Read more
Impact Snapshot
Event Time:
CEMI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CEMI alerts
Opt-in for
CEMI alerts

from News Quantified
Opt-in for
CEMI alerts

from News Quantified